PGEN
#1845
Precigen, Inc. - Common Stock
6.9 5 USD
0.00%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+0.29%
Changement Mensuel
+11.56%
Evolution sur 6 mois
+90.41%
Changement Annuel
+54.79%
Clôture Précédente
6.9 3
Open
6.9 4
Low
6.9 0
High
7.0 0
Volume
466
Financials
- Market Capitalization 2.49 B
- Employee 47
- Founded 1998
- CEO Helen Sabzevari
- Website www.precigen.com
- Headquarter Virginia, United States
- FIGI BBG000QL8VH9
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1833 |  RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 25.60 USD | +1.55% | -4.41% | +2.73% | -16.07% | 2.52 B USD | ||
| 1834 |  BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.86 USD | +1.65% | +1.34% | +9.56% | +17.80% | 2.52 B USD | ||
| 1850 |  VERA Vera Therapeutics, Inc. - Class A Common Stock | 34.34 USD | +0.76% | +0.23% | +7.92% | +15.47% | 2.47 B USD | ||
| 1851 |  NKTR Nektar Therapeutics - Common Stock | 72.47 USD | +1.53% | -3.11% | +2.47% | -1.09% | 2.47 B USD |